Stock search

Ticker or company name

Cooper Companies (The)

COO · NASDAQ · Health Care

$61,88Down −0,77 (−1,23%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$11,9 bn
Div. yield
<0,1%
Year to date
−23,6%
52 weeks: $51,01$89,83

Ratio score

89/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

7 ✓ · 2 — · 0 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM20,942,725,1
Forward P/E12,7—16,2
PEG3,1—2,2
P/S2,84,92,2
EV/EBITDA19,425,317,3
P/FCF17,6—19,5
P/B1,42,33,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 22 analysts

Buy
8
Hold
14
Sell
0

Beat the EPS forecast in 4 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20261,131,15Up +1,8%
Q2 20261,111,21Up +9,3%
Q1 20261,041,10Up +5,7%
Q4 20251,121,15Up +2,3%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue1,07 bn1,08 bn1,02 bn1,07 bn1,06 bn1,00 bn965 m1,02 bn1,00 bn943 m932 m927 m
EPS2,24−0,400,660,420,490,440,520,590,520,440,411,70
Margin40,6%−7,2%12,8%7,9%9,3%8,7%10,8%11,5%10,4%9,4%8,7%9,1%
FCF273 m96,4 m159 m150 m165 m18,1 m101 m128 m119 m36,9 m4,60 m29,2 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: purchases $3,18 m (7 people), no sales.

NameAmountSharesPrice
kurzius lawrence erik16 Sep 2026 · open-market purchase$549 32010 000$54,93
rosebrough walter m jr14 Sep 2026 · open-market purchase$162 8703 000$54,29
kurzius lawrence erik14 Sep 2026 · open-market purchase$539 15010 000$53,92
keel paul a11 Sep 2026 · open-market purchase$249 9994 701$53,18
rosebrough walter m jr11 Sep 2026 · open-market purchase$378 7707 000$54,11
lucchese cynthia l22 Dec 2025 · open-market purchase$149 9631 784$84,06
rivas maria18 Dec 2025 · open-market purchase$82 1301 000$82,13
kurzius lawrence erik17 Dec 2025 · open-market purchase$165 0002 000$82,50
sheffield holly r16 Dec 2025 · open-market purchase$99 3231 230$80,75
white albert g iii16 Dec 2025 · open-market purchase$808 00010 000$80,80

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NASDAQ
Country
US
IPO date
21 Jan 1983

Company description, revenue by segment and region, and the CEO will come later.

Next report
2 Dec 2026, after close

An AI summary of the earnings call will come later.

Peers

CompanyPrice
ALGNAlign Technology$165,9889would consider24,1+4,4%11,8%
DVADaVita$174,2272would consider11,9+6,4%6,5%
BAXBaxter International$25,5438would not consider—+5,3%−6,2%
UHSUniversal Health Services$197,8078would consider7,8+8,0%8,0%
PODDInsulet Corporation$145,2989would consider24,7+26,5%13,4%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.